No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abdominal Wall / pathology
-
Adult
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Chemotherapy, Adjuvant
-
Disease Progression
-
Drug Administration Schedule
-
Female
-
Gastrointestinal Stromal Tumors / genetics*
-
Gastrointestinal Stromal Tumors / pathology
-
Gastrointestinal Stromal Tumors / secondary
-
Germ-Line Mutation
-
Humans
-
Imatinib Mesylate / administration & dosage
-
Imatinib Mesylate / therapeutic use*
-
Mutation*
-
Paraganglioma / genetics*
-
Paraganglioma / pathology
-
Paraganglioma / secondary
-
Protein Kinase Inhibitors / therapeutic use
-
Proto-Oncogene Proteins c-kit / genetics*
-
Receptor, Platelet-Derived Growth Factor alpha / genetics*
-
Rectal Neoplasms / genetics*
-
Rectal Neoplasms / pathology
-
Succinate Dehydrogenase / genetics*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
SDHD protein, human
-
Imatinib Mesylate
-
Succinate Dehydrogenase
-
Proto-Oncogene Proteins c-kit
-
Receptor, Platelet-Derived Growth Factor alpha
Supplementary concepts
-
Carney-Stratakis Syndrome